BCL2L1 and invasive carcinoma: Our findings implicating Bcl-x in invasion are notable in light of a recent study by Du et al., who reported a significant increase in the incidence of invasive carcinomas in RIP1-Tag2 mice engineered to focally over-express Bcl-xL via retrovirus-mediated somatic gene transfer into neoplastic lesions [32].